Table 1 Demographic and clinical data
From: Cytotoxic response persists in subjects treated for tuberculosis decades ago
Patient groups | n | Finns n (%) | Age range | Female sex n (%) | AFB pos. n (%) | Culture pos. n (%) | Other method n (%) |
|---|---|---|---|---|---|---|---|
Active-TB (TB) | Â | Â | Â | Â | Â | Â | Â |
Pulmonary | 18 | 14 (78) | 27 - 81 | 6 (33) | 14 (78) | 17 (94) | Clinical presentation and response to treatment: 1 (6) |
Other organs | 3 | 2 (67) | 33 - 62 | 1 (33) | 0 (0) | 3 (100) | Â |
LTBI | 11 | 10 (91) | 43 - 80 | 4 (36) | n/d | n/d | IGRA pos: 11 (100) |
Treated patients - no chemotherapy (Surg.) | 6 | 6 (100) | 53 - 83 | 2 (33) | n/d | n/d | n/d |
Treated patients - partial treatment (Part.) | 23 | 23 (100) | 71 - 90 | 18 (78) | n/d | n/d | n/d |
Treated patients - modern three-drug treatment (Mod.) | 8 | 7 (86) | 45 - 84 | 7 (86) | n/d | n/d | n/d |
Healthy BCG-vaccinees (BCG) | 6 | 6 (100) | 33 - 44 | 6 (100) | n/d | n/d | IGRA neg.: 6 (100) |